Trial Profile
A Retrospective, cohort study to evaluate the transition to Everolimus or Mycophenolate Mofetil and it effect on the renal function in Renal Transplant patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 May 2017
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Mycophenolate mofetil
- Indications Liver transplant rejection
- Focus Pharmacodynamics
- 10 May 2017 New trial record
- 03 May 2017 Results presented at the 2017 American Transplant Congress